Novo Holdings A/S as of June 30, 2023
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 41 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Asml Holding N V N Y Registry Shs (ASML) | 11.1 | $143M | 198k | 724.75 | |
| salesforce (CRM) | 8.7 | $112M | 531k | 211.26 | |
| Lanzatech Global (LNZA) | 8.3 | $108M | 16M | 6.83 | |
| Corcept Therapeutics Incorporated (CORT) | 5.8 | $75M | 3.4M | 22.25 | |
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 5.5 | $72M | 711k | 100.92 | |
| Cable One (CABO) | 4.8 | $62M | 94k | 657.08 | |
| Disc Medicine (IRON) | 3.7 | $48M | 1.1M | 44.40 | |
| Edgewise Therapeutics (EWTX) | 3.6 | $47M | 6.1M | 7.75 | |
| Mirum Pharmaceuticals (MIRM) | 3.4 | $44M | 1.7M | 25.87 | |
| Apple (AAPL) | 3.3 | $43M | 222k | 193.97 | |
| Vaxcyte (PCVX) | 3.3 | $42M | 845k | 49.94 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 3.2 | $42M | 501k | 83.35 | |
| BioMarin Pharmaceutical (BMRN) | 2.7 | $35M | 400k | 86.68 | |
| Arcellx Common Stock (ACLX) | 2.4 | $32M | 1.0M | 31.62 | |
| Seagen | 2.4 | $31M | 160k | 192.46 | |
| Blueprint Medicines (BPMC) | 2.2 | $28M | 449k | 63.20 | |
| Insmed Com Par $.01 (INSM) | 2.2 | $28M | 1.3M | 21.10 | |
| Amicus Therapeutics (FOLD) | 2.0 | $26M | 2.1M | 12.56 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $23M | 118k | 189.94 | |
| Cymabay Therapeutics | 1.7 | $22M | 2.0M | 10.95 | |
| Reneo Pharmaceuticals (RPHM) | 1.7 | $22M | 3.3M | 6.56 | |
| Brookfield Asset Mgmt Cl A Ltd Vt Sh | 1.6 | $21M | 627k | 32.63 | |
| Pharvaris N V (PHVS) | 1.6 | $20M | 1.3M | 15.14 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.5 | $20M | 1.1M | 18.02 | |
| Rocket Pharmaceuticals (RCKT) | 1.4 | $18M | 920k | 19.87 | |
| 4d Molecular Therapeutics In (FDMT) | 1.4 | $18M | 1.0M | 18.07 | |
| Spruce Biosciences (SPRB) | 1.1 | $15M | 6.7M | 2.15 | |
| Rallybio Corp (RLYB) | 1.0 | $12M | 2.2M | 5.66 | |
| Silk Road Medical Inc Common | 0.8 | $11M | 334k | 32.49 | |
| Inspire Med Sys (INSP) | 0.8 | $11M | 33k | 324.64 | |
| Cyteir Therapeutics | 0.7 | $9.5M | 3.7M | 2.60 | |
| Verve Therapeutics (VERV) | 0.7 | $9.4M | 500k | 18.75 | |
| Treace Med Concepts (TMCI) | 0.7 | $9.2M | 360k | 25.58 | |
| Abcellera Biologics (ABCL) | 0.6 | $7.3M | 1.1M | 6.46 | |
| Galera Therapeutics (GRTX) | 0.5 | $6.6M | 2.1M | 3.12 | |
| Io Biotech (IOBT) | 0.5 | $6.4M | 3.3M | 1.96 | |
| Galecto (GLTO) | 0.5 | $6.3M | 2.5M | 2.52 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.4 | $4.9M | 2.4M | 2.03 | |
| Kinnate Biopharma | 0.2 | $2.5M | 816k | 3.03 | |
| Marqeta Class A Com (MQ) | 0.2 | $2.2M | 442k | 4.87 | |
| Spero Therapeutics (SPRO) | 0.1 | $680k | 469k | 1.45 |
